– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...
Injectafer (ferric carboxymaltose) is a prescription drug that’s used to treat iron deficiency anemia. Injectafer comes as a liquid solution for intravenous (IV) injection or infusion. It’s always ...
Precision Bb Targeting, Robust Efficacy, Transfusion Independence, Excellent Safety in Phase II PNH Study, and Subcutaneous Administration The 12-16-week open-label study evaluated Ruxoprubart as ...
The benefit of reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) as salvage treatment for relapsing multiple myeloma (MM) Bortezomib (Bz) is a novel proteasome ...
One experimental injection helped mice and pigs heal after heart attack by boosting a protective heart hormone. (CREDIT: ...
The IV and injection formulations support the rapid and efficient delivery of Niagen. Outperforming NAD+ IV in the pilot clinical study, Niagen IV offered superior tolerability, a 75% shorter infusion ...
A new study published in the journal of BMC Nephrology showed that subcutaneous and intravenous epoetin showed similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results